Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

China flag China · Delayed Price · Currency is CNY
14.06
+0.13 (0.93%)
Apr 30, 2026, 12:54 PM CST
0.79%
Market Cap 5.82B
Revenue (ttm) 827.14M
Net Income (ttm) 65.09M
Shares Out 417.60M
EPS (ttm) 0.16
PE Ratio 89.35
Forward PE n/a
Dividend 0.08 (0.54%)
Ex-Dividend Date n/a
Volume 1,759,900
Average Volume 4,342,062
Open 13.80
Previous Close 13.93
Day's Range 13.80 - 14.14
52-Week Range 12.84 - 22.69
Beta -0.08
RSI 49.24
Earnings Date Apr 24, 2026

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1996
Employees 1,384
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002907
Full Company Profile

Financial Performance

In 2025, SHE:002907's revenue was 827.14 million, an increase of 6.75% compared to the previous year's 774.82 million. Earnings were 65.09 million, a decrease of -15.17%.

Financial Statements

News

There is no news available yet.